MindMaze Therapeutics Holding S.A. (RLFTF)
Stock analysis · OTC · Healthcare · Biotechnology
$0.22
Market Cap
$2.81M
PE (TTM)
-0.38
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.23
Day Range
$0.22 – $0.24
52-wk Range
$0.16 – $4.88
Avg Volume
N/A
Volume
50.00
MindMaze Therapeutics Holding S.A. (RLFTF) is a publicly traded company in the Healthcare sector. Latest price: $0.22. Market cap $2.81M. Trailing PE -0.38. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About MindMaze Therapeutics Holding S.A.
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Valuation
| P/E (TTM) | -0.38× |
|---|---|
| P/S (TTM) | 3.60× |
| P/B | 0.10× |
| P/FCF (TTM) | -0.18× |
| EV / EBITDA | 0.62× |
| EV / Sales | -8.34× |
| Earnings Yield | -261.52% |
| Free Cash Flow Yield | -568.57% |
Fundamentals
| Enterprise Value | -$5.36M |
|---|---|
| Net Income (TTM) | -$6.04M |
| Free Cash Flow (TTM) | -$12.86M |
| Net Debt | -$7.67M |
| Working Capital | $2.22M |
| Gross Margin | -163.08% |
| Operating Margin | -1637.85% |
| Net Margin | -1542.99% |
| Return on Equity | -27.92% |
| Return on Invested Capital | -25.50% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap